Healthcare Venture Capital
Why Johnson & Johnson is investing in this niche telehealth startup | FierceHealthcare | 8/17/2020
… York City-based Thirty Madison offers telehealth visits and online prescriptions for drugs for hair loss, migraines and acid reflux. Thirty Madison has scored $47 million in a series B funding round led by healthcare venture capital firm Polaris Partners. Webinar Against Coronavirus, Knowledge is Power For organizations with a need for affordable and convenient COVID-19 antibody testing, Truvian’s Easy Check COVID-19 IgM/IgG antibody test empowers onsite …
Women in Bio: Geeta Vemuri Blazes a Trail in Venture Capital | 7/29/2020
Geeta Vemuri is a trailblazer. Following her time as a Managing Partner at Baxter Ventures and Baxalta Ventures, Vemuri founded Agent Capital, a healthcare venture capital firm focused on investing in novel, differentiated therapeutics and treatments that address unmet patient needs. With the launch of Agent Capital, Vemuri is one of four women in the biopharma sector who have founded a venture capital group. The amount of money invested in …
… asset in Canadian history and worldwide academia Read more about the community impact of this investment here. VC Private Capital Regional Impact Award for Western Canada Lumira Ventures is Canada’s leading and most active healthcare venture capital firm. Lumira invests in best-in-class North American companies developing innovative therapeutics and medical technologies whose products offer transformative improvements to patient health outcomes and provide meaningful reductions to the overall cost …
… natural degradation of cell products – to destroy cancer-causing proteins that cannot be targeted by current drug types. Monte Rosa has secured an initial $32.5m of funding from its founding investor Versant Ventures, a healthcare venture capital firm, and New Enterprise Associates. It will soon launch another round of financing to raise funds to run clinical studies of some of its leading drug candidates. Now based in Boston in the …
Cobalt Taps iLevel Co-founder Hank Boggio to be Chief Commercial Officer | PR Newswire | 6/9/2020
… in the first half of 2020. Clients Cobalt has signed during that period, the majority focused on portfolio monitoring, include: American Family Insurance (AmFam) , the private insurance firm with direct investing Heritage Group , the healthcare venture capital firm Hastings Equity Partners , the energy sector buyout firm Kainos Capital , the food and consumer sector-focused private equity firm Liberty Hall Capital Partners , the global aerospace and defense-focused private equity firm …
… and offer unique deal access to our investors, compelling returns should follow.” About Tidewater Equity Partners: Tidewater Equity Partners is a North Carolina investment firm focusing on small company direct investment as well as healthcare venture capital . Tidewater provides unique access to small company private equity and venture capital investments for high-net-worth individuals, family offices, and small institutional investors. For More Information on Tidewater Equity Partners : Please visit …
We will get to that on page 35… — PowerPoint templates and presentation design services | 4/1/2020
We will get to that on page 35… – Working from home means that I cannot help to overhear fragments of startups pitching to a VC (my wife is a partner in a healthcare venture capital fund). You are in a Zoom call, going through a deck with a few people from the VC, and the senior management team of the company on the line. One of the impatient investors throws …
… CEO and Co-Founder, Brent Vaughan, will be staying on in an advisory capacity to support Happel and the Cognoa team through the transition and moving into a new role with Morningside Group, a healthcare venture capital firm and Cognoa’s lead investor. “I am incredibly proud of what we have achieved at Cognoa to advance the standard of care in pediatric behavioral health” said Vaughan of his time leading Cognoa …
… CEO and Co-Founder, Brent Vaughan, will be staying on in an advisory capacity to support Happel and the Cognoa team through the transition and moving into a new role with Morningside Group, a healthcare venture capital firm and Cognoa’s lead investor. “I am incredibly proud of what we have achieved at Cognoa to advance the standard of care in pediatric behavioral health” said Vaughan of his time leading Cognoa …
Versant Ventures Announces Successful IPO by Black Diamond Therapeutics | Business Wire | 1/30/2020
… HER2 allosteric mutants. The most advanced product candidate, BDTX-189, is expected to start a combined Phase 1/2 clinical trial in the first half of 2020. About Versant Ventures Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $3.2 billion under management and …
Inovio Welcomes Biotech Leader to its Board of Directors | PR Newswire | 1/15/2020
… Officer of Aravive, a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. Previously, Mr. Shepard was an Executive Partner at Sofinnova Ventures, a healthcare venture capital firm. Before that he also served as President and Chief Executive Officer and was a member of the board of directors of NextWave Pharmaceuticals, Inc., a specialty pharmaceutical company developing and commercializing unique …
… a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs. For more information, please visit www.tyra.bio . ABOUT ALTA PARTNERSFounded in 1996, Alta Partners is one of the nation’s premier healthcare venture capital firms, investing in many of the industry’s most successful companies. Alta has offices in San Francisco and Denver . For more information, please visit www.altapartners.com . ABOUT RA CAPITAL MANAGEMENTRA Capital is a multi-stage …
… and their application in the real-world to improve health outcomes and lower the total cost of care. About Merck Global Health Innovation Fund Merck Global Health Innovation Fund (Merck GHIF) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions. Merck GHIF has $500M under management and provides growth capital to emerging …
Conference Davos WEF Healthcare Venture Capital Sustainable Practices Alex Kopelyan General Partner at Indie Bio Interview with Host Matt Bird at DAVOS2019 Traders Network Show - World Economic Forum Matt Bird Follow Tuesday, 31 December 2019 12:12 (EST) HIGHLIGHTS Early stage venture fund & accelerator in biotech Focus on seafood sustainability initiatives Goal: To create alternatives on how to save our oceans Event: World Economic Forum (DAVOS) Alex Kopelyan, General Partner at …
… report, about three-quarters of male and female respondents predicted their workplaces will achieve gender parity within the next 25 years. However, according to the report’s projections, even if 50 percent of all new healthcare venture capital partners hired are women, it will be nearly a century before they make up even 45 percent of the industry, and it would take more than 70 years for the top healthcare companies …
… of Business Development and Strategic Partnerships at Edico Genome; and held leadership roles at Illumina. Truvian’s Board of Directors is chaired by Truvian Co-founder Kim Kamdar , Ph.D., a Partner with Domain Associates, a healthcare venture capital leader. Dr. Kamdar states, “The Board is especially encouraged by the support Truvian has received from the investment community and are pleased by the caliber of industry veterans who have joined the company …
AHA, Concord Health Partners close $50M health tech venture round | FierceHealthcare | 11/13/2019
… health systems are entering the venture world or doubling down. For instance, earlier this year Seattle-based Providence Ventures, the venture capital arm of Providence St. Joseph Health, raised $150 million for its second healthcare venture capital and growth equity fund. “Providers of all sizes, types and tax statuses, including Tenet, Trinity and Community Health Systems have begun investing in externally run funds,” the AHA wrote in a blog earlier …
BALTIMORE , Nov. 11, 2019 /PRNewswire/ – The U.S. healthcare market saw a 14.4 percent increase in mergers and acquisitions from 2017-2018, fueled by soaring domestic venture capital investment – an all-time high of $130.9 billion invested in U.S.-based startups in 2018 alone. Compounding the pace and complexity of deal flow are sweeping industry trends ranging from managing and measuring health outcomes to reducing the overall cost of care. Given this …
LifeSciences BC Attracts International Audience for Annual Investor’s Summit | 11/6/2019
Blog This Today , LifeSciences BC , a non-profit, industry association which supports and represents the life sciences community of British Columbia, and Lumira Ventures , a leading North American healthcare venture capital firm, will host the 4 th annual LifeSciences BC’s Investor Summit in Vancouver, BC. The event brings together industry stakeholders from the healthcare innovation ecosystem for company pitching and fostering strategic partnerships with international investors. The day kicks off …
VANCOUVER, British Columbia–(BUSINESS WIRE)–Nov 6, 2019– Today , LifeSciences BC , a non-profit, industry association which supports and represents the life sciences community of British Columbia, and Lumira Ventures , a leading North American healthcare venture capital firm, will host the 4 th annual LifeSciences BC’s Investor Summit in Vancouver, BC. The event brings together industry stakeholders from the healthcare innovation ecosystem for company pitching and fostering strategic partnerships with …
… times in the last 18 years. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672). About ShangPharma Innovation Inc. ShangPharma Innovation Inc. is a healthcare venture capital firm that accelerates and facilitates pharmaceutical discovery and development. With a focus on therapeutics and technology platforms, ShangPharma Innovation offers funding, incubator space and other support to its ecosystem of portfolio companies, collaborators …
Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch | 10/30/2019
… biotech companies are in line for an early Christmas present. On Tuesday morning, US Secretary of the Treasury Steven Mnuchin met with Israeli health officials and Marius Nacht, co-founder of life sciences and healthcare venture capital fund aMoon, to discuss the opening of a local branch of the US Food and Drug Administration, according to one person who spoke to Calcalist on condition of anonymity. The meeting was held …
The Company Alexandria Real Estate Equities ( ARE ) is an almost-pure-play investment on life science real estate. In other words, it owns and leases over 37 million square feet of office and laboratory space to pharmaceutical and biotechnology companies. Its 250 properties are mostly concentrated in high-end locations such as New York City, San Francisco, San Diego, Seattle, Cambridge (Massachusetts), and the “Research Triangle” in North Carolina. Rendering …
Sofinnova Capital IX raises 333 mln euros | PE Hub | 10/17/2019
Sofinnova Capital IX raises 333 mln euros October 17, 2019 Sofinnova Partners said Oct. 17 that its latest early-stage healthcare venture capital fund closed on 333 million euros ($370.3 million). Sofinnova Capital IX will invest in the healthcare industry and more specifically in the biopharmaceutical and medical device sectors. PRESS RELEASE SOFINNOVA PARTNERS RAISES €333 MILLION CAPITAL IX EARLY-STAGE HEALTHCARE FUND The firm manages €2B across its life …
… Sofinnova Partners , a leading European venture capital firm based in Paris, London and Milan and specialized in Life Sciences. Today, Sofinnova announced it has closed $370.3 million ( €333 million) for its latest early-stage healthcare venture capital fund Sofinnova Capital IX. The firm now has more than €2B under management with more than €1B raised in the last four years across its platform of life sciences funds. Founded about half …
Digital Health
… drugs. For more information, please visit www.tyra.bio . ABOUT ALTA PARTNERSFounded in 1996, Alta Partners is one of the nation’s premier healthcare venture capital firms, investing in many of the industry’s most successful companies. Alta has … the next generation of consumer, fintech, frontier tech, biotech and digital health companies that will transform how we live, work and thrive. To learn more about our people and our portfolio, please visit www.canaan.com . CONTACT …
… healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions. Merck GHIF has $500M under management and provides growth capital to emerging healthcare technology companies worldwide while leveraging the vast R&D-based, global resources of Merck. With a vision that data will be the currency in healthcare, GHIF invests broadly in digital health. GHIF invests …
Food and Drug Administration
… Capital Partners along with existing investor Domain Associates — to support the acceleration of the company which is developing a U.S. Food and Drug Administration (FDA)-cleared automated benchtop system to provide lab accurate results in … founder Kim Kamdar , Ph.D., a Partner with Domain Associates, a healthcare venture capital leader. Dr. Kamdar states, “The Board is especially encouraged by the support Truvian has received from the investment community and are pleased …
Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch | 10/30/2019
… healthcare venture capital fund aMoon, to discuss the opening of a local branch of the US Food and Drug Administration, according to one person who spoke to Calcalist on condition of anonymity. The meeting was held at the house of US Ambassador to Israel David Friedman, and was attended by senior executives from Israeli health maintenance organization Clalit and Sheba Medical Center. The FDA, a federal agency based in Washington …
Biotech
… healthcare venture capital firm that accelerates and facilitates pharmaceutical discovery and development. With a focus on therapeutics and technology platforms, ShangPharma Innovation offers funding, incubator space and other support to its ecosystem of portfolio companies, collaborators and partners. This includes sponsoring biotech start-ups and proof-of-concept research at major academic and medical centers and research institutes. ShangPharma maintains an active relationship with its affiliate and preferred provider, ChemPartner …
Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch | 10/30/2019
Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch October 30, 2019 0 Israeli medtech and biotech companies are in line for an early Christmas present. On Tuesday morning, US Secretary of the Treasury Steven Mnuchin met with Israeli health officials and Marius Nacht, co-founder of life sciences and healthcare venture capital fund aMoon, to discuss …
Clinical Data
… for patient selection for Plinabulin at the American Association for Cancer Research Annual Meeting. At the same conference, BeyondSpring presented preclinical data demonstrating Plinabulin’s ability to reduce tumor-associated M2 macrophages, which are thought to … Agreements”) to certain investors led by Efung Capital, a leading healthcare venture capital fund. Under the Equity Purchase Agreements, Wanchun Bulin expects to sell equity interests representing 4.76% of the equity of Wanchun Bulin for …
… for patient selection for Plinabulin at the American Association for Cancer Research Annual Meeting. At the same conference, BeyondSpring presented preclinical data demonstrating Plinabulin’s ability to reduce tumor-associated M2 macrophages, which are thought to … Agreements”) to certain investors led by Efung Capital, a leading healthcare venture capital fund. Under the Equity Purchase Agreements, Wanchun Bulin expects to sell equity interests representing 4.76% of the equity of Wanchun Bulin for …
Novartis
Versant Ventures Announces Successful IPO by Black Diamond Therapeutics | Business Wire | 1/30/2020
… laboratories were established during March 2017 with a team of accomplished discovery scientists from leading pharmaceutical companies including Roche and Novartis. The mission was to enable entrepreneurs to more effectively launch and progress Versant-backed … of 2020. About Versant Ventures Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are …
Versant Ventures Announces Successful IPO by Black Diamond Therapeutics | Business Wire | 1/30/2020
… laboratories were established during March 2017 with a team of accomplished discovery scientists from leading pharmaceutical companies including Roche and Novartis. The mission was to enable entrepreneurs to more effectively launch and progress Versant-backed … of 2020. About Versant Ventures Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are …
Inovio
Inovio Welcomes Biotech Leader to its Board of Directors | PR Newswire | 1/15/2020
PLYMOUTH MEETING, Pa. , Jan. 15, 2020 /PRNewswire/ – Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced the appointment of Jay Shepard to its Board of Directors. Mr. Shepard brings broad healthcare and financial experience to the board given his tenure as CEO of several biotech companies, his multiple corporate board appointments and his expertise as a healthcare venture capitalist. Dr. J. Joseph Kim , Inovio’s President & CEO said, “We are fortunate to have …
Inovio Welcomes Biotech Leader to its Board of Directors | BioSpace | 1/15/2020
PLYMOUTH MEETING, Pa. Inovio Pharmaceuticals Inc. (NASDAQ:INO) today announced the appointment of Jay Shepard to its Board of Directors. Mr. Shepard brings broad healthcare and financial experience to the board given his tenure as CEO of several biotech companies, his multiple corporate board appointments and his expertise as a healthcare venture capitalist. Dr. J. Joseph Kim , Inovio’s President & CEO said, “We are fortunate to have Jay Shepard join Inovio’s …
Pfizer
Inovio Welcomes Biotech Leader to its Board of Directors | PR Newswire | 1/15/2020
… board given his tenure as CEO of several biotech companies, his multiple corporate board appointments and his expertise as a healthcare venture capitalist. Dr. J. Joseph Kim , Inovio’s President & CEO said, “We are fortunate to … products utilizing proprietary drug delivery technology that was acquired by Pfizer, Inc. Mr. Shepard has also served as President and Chief Executive Officer and a member of the board of directors of Ilypsa, Inc., a …
… by blue chip investors including: AbbVie Ventures, Andera Partners, Arix Bioscience, IP Group plc, LSP, M Ventures, Novartis Venture Fund, Pfizer Ventures and SV Health Investors. Artios is based in Cambridge, UK and New York … CA016672). About ShangPharma Innovation Inc. ShangPharma Innovation Inc. is a healthcare venture capital firm that accelerates and facilitates pharmaceutical discovery and development. With a focus on therapeutics and technology platforms, ShangPharma Innovation offers funding, incubator …
Merck
… an extension of their Series D funding round, bringing the amount raised to $28 million , thanks to an investment from Merck Global Health Innovation Fund (GHI). The extension brings the total capital raised to date … Merck Global Health Innovation Fund (Merck GHIF) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions. Merck …
… Frohlich was vice president of business development at Arbutus Biopharma, and prior to that worked internationally at Johnson & Johnson and Merck in various roles leading commercial strategy across all stages of product development including the … visit www.chinooktx.com . About Versant Ventures Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are …
Quest Diagnostics
… changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. Founded in 2005, Sage Growth Partners is located in Baltimore, MD and serves clients such as Philips Healthcare, Quest Diagnostics, Hughes and Company, Olive, It’s Never 2 Late, and Noro-Moseley Partners. Visit us online at www.sage-growth.com . Media Contact Vanessa Ulrich (410) 534.1161 [email protected] SOURCE Sage Growth Partners Related Links http://www.sage …
… artificial intelligence (AI) solutions and digital media properties, today commented on the recently announced strategic investment in Sharecare led by Quest Diagnostics. “We are proud to have been a founding technology partner of Sharecare, supporting … most watched digital health companies having been highlighted by digital healthcare venture capital fund Rock Health’s 12- Month Anticipated IPO Watch List (https://www.businessinsider.com/10-digital-health-startups-poised-to-ipo-zocdoc-23andme-heartflow-2019-7 …
Sofinnova Partners
Sofinnova Capital IX raises 333 mln euros | PE Hub | 10/17/2019
Sofinnova Capital IX raises 333 mln euros October 17, 2019 Sofinnova Partners said Oct. 17 that its latest early-stage healthcare venture capital fund closed on 333 million euros ($370.3 million). Sofinnova Capital IX will invest in the healthcare industry and more specifically in the biopharmaceutical and medical device sectors. PRESS RELEASE SOFINNOVA PARTNERS RAISES €333 MILLION CAPITAL IX EARLY-STAGE HEALTHCARE FUND The firm manages €2B across its life …
PARIS- Sofinnova Partners, a leading European venture capital firm based in Paris, London and Milan and specialized in Life Sciences, announced today the close of its latest early-stage healthcare venture capital fund Sofinnova Capital IX, oversubscribed at €333 million. The firm now has more than €2B under management with more than €1B raised in the last four years across its platform of life sciences funds. Pursuing the strategy it …
Innovation Fund
… their Series D funding round, bringing the amount raised to $28 million , thanks to an investment from Merck Global Health Innovation Fund (GHI). The extension brings the total capital raised to date to $66 million … Merck Global Health Innovation Fund (Merck GHIF) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions. Merck …
AHA, Concord Health Partners close $50M health tech venture round | FierceHealthcare | 11/13/2019
by Tina Reed Nov 13, 2019 3:15pm The AHA Innovation Fund was formed to invest in early-stage healthcare companies that provide products, services and solutions that help hospitals and health systems transform care delivery … Providence St. Joseph Health, raised $150 million for its second healthcare venture capital and growth equity fund. “Providers of all sizes, types and tax statuses, including Tenet, Trinity and Community Health Systems have begun investing …
Silicon Valley Bank
Silicon Valley Bank Expands In Arizona | PR Newswire | 11/12/2019
TEMPE, Ariz. , Nov. 12, Silicon Valley Bank (SVB), the bank of the world’s most innovative companies and their investors, today announced its expansion in Arizona . The bank has secured an additional 60,000 square feet of office space in Tempe that it will move into in Q1 2020 and aims to grow its presence by more than 300 employees in the next three years. “We’re pleased to expand our presence in …
SANTA CLARA, Calif. , Jan. 4, 2018 /PRNewswire/ – Healthcare venture capital fundraising set a record of $9.1 billion in 2017, increasing 26 percent over 2016, according to Silicon Valley Bank (SVB), the bank of the world’s most innovative companies and their investors. Investments into venture capital-backed biopharma, medical device and diagnostics/tools companies also are expected to break a record in 2017 when the final numbers are compiled for the …
Optum Ventures
Kaia Health nets $8m in latest funding round | 9/18/2019
Credit: Kaia Health Digital therapeutics company Kaia Health has announced the closure of an $8m funding round led by healthcare venture capital firm Optum Ventures. The money will be used to accelerate the company’s sales growth in the US, as well as extending its platform and expanding the supporting clinical evidence base for its technology. This is Kaia’s second significant fundraising of 2019, following $10m in Series A funding from …
Healthcare venture capital is growing: 16 latest deals | Becker’s Hospital Review | 4/25/2019
Venture capitalists poured $2.6 billion into healthcare startups in January, and dozens of healthcare venture capital deals have been announced since then. Below are 16 healthcare venture capital deal announced in the past month: 1 … raised $9.6 million in Series A-1 funding led by Optum Ventures. 9. EveryWell , an Austin, Texas-based digital health company, raised $50 million in financing led by Goodwater Capital. 10. Sword Health , a New …
New Enterprise Associates
… their field. Co-founders Kirk Nielsen and Justin Klein, M.D., J.D., were previously leading medtech-focused investors at Versant and New Enterprise Associates, respectively. “We are grateful for the trust and confidence of our limited … medtech fund. About Versant Ventures Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are …
… field. Co-founders Kirk Nielsen and Justin Klein, M.D., J.D., were previously leading medtech-focused investors at Versant Ventures and New Enterprise Associates, respectively. In the aggregate, they have led capital raises for healthcare start … at www.vensanacap.com . About Versant Ventures Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are …
Versant Ventures
Versant Ventures Enables Launch of Vensana Capital to Focus on Medtech Sector Sep 4, 2019 Save SAN FRANCISCO & NEW YORK & VANCOUVER, British Columbia & BASEL, Switzerland–(BUSINESS WIRE)–Sep 4, 2019– Since it was conceived, Versant … medtech fund. About Versant Ventures Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are …
… of interest to the firm include medical devices, diagnostics and data science, drug delivery, digital health, and tech-enabled services. Versant Ventures has supported the launch of the independent new firm and will continue to … at www.vensanacap.com . About Versant Ventures Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are …
HealthCare Ventures
Schrödinger Appoints Dov Goldstein, M.D., as Chief Financial Officer | PR Newswire | 11/2/2017
… years of strategic financial experience in the healthcare sector, most recently as a Managing Partner at Aisling Capital, a leading healthcare venture capital and private equity firm with over $1.8 billion under management, where he … Oncology. Previously, Dr. Goldstein was Director of Venture Analysis at Healthcare Ventures, where he led due diligence for new investments and business development for portfolio companies. Prior to joining the financial industry, he completed his …
Schrödinger Appoints Dov Goldstein, M.D., as Chief Financial Officer | PR Newswire | 11/2/2017
… years of strategic financial experience in the healthcare sector, most recently as a Managing Partner at Aisling Capital, a leading healthcare venture capital and private equity firm with over $1.8 billion under management, where he … Oncology. Previously, Dr. Goldstein was Director of Venture Analysis at Healthcare Ventures, where he led due diligence for new investments and business development for portfolio companies. Prior to joining the financial industry, he completed his …
Aisling Capital
Schrödinger Appoints Dov Goldstein, M.D., as Chief Financial Officer | PR Newswire | 11/2/2017
… Aisling Capital, a leading healthcare venture capital and private equity firm with over $1.8 billion under management, where he sourced and led investments in private and public companies, including as a Board Director of 5 companies that went public. (PRNewsfoto/Schrödinger)… “We are thrilled to welcome Dov to our leadership team as he brings significant depth of financial experience and a proven track record of successfully spearheading and guiding financial …
Schrödinger Appoints Dov Goldstein, M.D., as Chief Financial Officer | PR Newswire | 11/2/2017
NEW YORK , Nov 2, Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, today announced the appointment of Dov Goldstein , M.D., as Chief Financial Officer. Dr. Goldstein brings to Schrödinger over 20 years of strategic financial experience in the healthcare sector, most recently as a Managing Partner at Aisling Capital, a leading healthcare venture capital and private equity firm with over $1.8 billion under …
Steven Mnuchin
Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch | 10/30/2019
Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch October 30, 2019 0 Israeli medtech and biotech companies are in line for an early Christmas present. On Tuesday morning, US Secretary of the Treasury Steven Mnuchin met with Israeli health officials and Marius Nacht, co-founder of life sciences and healthcare venture capital fund aMoon, to discuss …
Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch | 10/29/2019
US Treasury Secretary Steven Mnuchin announces the Trump administration’s economic sanctions against the Venezuelan state owned oil company Petroleos de Venezuela (PdVSA) during a press briefing at the White House in Washington, US, January 28 … officials and Marius Nacht, co-founder of life sciences and healthcare venture capital fund aMoon, to discuss the opening of a local branch of the US Food and Drug Administration, according to one person who …
Antoine Papiernik
Sofinnova Capital IX raises 333 mln euros | PE Hub | 10/17/2019
… Sofinnova Capital IX raises 333 mln euros October 17, 2019 Sofinnova Partners said Oct. 17 that its latest early-stage healthcare venture capital fund closed on 333 million euros ($370.3 million). Sofinnova Capital IX will … U.S. and Canada, as well as major investors from Asia. Antoine Papiernik, Managing Partner and Chairman of Sofinnova Partners, said, “Our experienced team, stable strategy and exit track record resonated well with investors, hence the …
… based in Paris, London and Milan and specialized in Life Sciences, announced today the close of its latest early-stage healthcare venture capital fund Sofinnova Capital IX, oversubscribed at €333 million. The firm now has … U.S. and Canada, as well as major investors from Asia. Antoine Papiernik, Managing Partner and Chairman of Sofinnova Partners, said, “Our experienced team, stable strategy and exit track record resonated well with investors, hence the …
Christoph Westphal
Recros Medica Closes $9M Financing, Strengthens Board | PR Newswire | 1/4/2018
… that it has closed a $9M financing. Additionally, the company is strengthening its Board of Directors with the additions of Christoph Westphal , MD, PhD and Mark Kerslake . “We are grateful for the additional financial resources … Longwood Fund Longwood Fund is one of the top-performing healthcare venture capital firms that founds, manages, and builds healthcare companies. Longwood’s mission is to identify technologies and found companies that make a difference in …
Recros Medica Closes $9M Financing, Strengthens Board | PR Newswire | 1/4/2018
… that it has closed a $9M financing. Additionally, the company is strengthening its Board of Directors with the additions of Christoph Westphal , MD, PhD and Mark Kerslake . “We are grateful for the additional financial resources … Longwood Fund Longwood Fund is one of the top-performing healthcare venture capital firms that founds, manages, and builds healthcare companies. Longwood’s mission is to identify technologies and found companies that make a difference in …
Benson Tsang
ShangPharma Innovation Names Two Executives-In-Residence | PR Newswire | 10/24/2017
… and innovation incubator focused on biomedical R&D therapeutics and technologies, announced the appointment of Dirk G. Brockstedt , Ph.D., and Benson Tsang , MBA, to its Executive-In-Residence (EIR) team. ShangPharma Innovation’s esteemed EIR team … About ShangPharma Innovation Inc. ShangPharma Innovation Inc. is a novel healthcare venture capital firm founded in the U.S. in 2016. ShangPharma Innovation accelerates and facilitates pharmaceutical discovery and development – focusing on therapeutics and technology platforms …
ShangPharma Innovation Names Two Executives-In-Residence | PR Newswire | 10/24/2017
… and innovation incubator focused on biomedical R&D therapeutics and technologies, announced the appointment of Dirk G. Brockstedt , Ph.D., and Benson Tsang , MBA, to its Executive-In-Residence (EIR) team. ShangPharma Innovation’s esteemed EIR team … About ShangPharma Innovation Inc. ShangPharma Innovation Inc. is a novel healthcare venture capital firm founded in the U.S. in 2016. ShangPharma Innovation accelerates and facilitates pharmaceutical discovery and development – focusing on therapeutics and technology platforms …
Dirk G. Brockstedt
ShangPharma Innovation Names Two Executives-In-Residence | PR Newswire | 10/24/2017
… a global venture capital firm and innovation incubator focused on biomedical R&D therapeutics and technologies, announced the appointment of Dirk G. Brockstedt , Ph.D., and Benson Tsang , MBA, to its Executive-In-Residence (EIR) team … About ShangPharma Innovation Inc. ShangPharma Innovation Inc. is a novel healthcare venture capital firm founded in the U.S. in 2016. ShangPharma Innovation accelerates and facilitates pharmaceutical discovery and development – focusing on therapeutics and technology platforms …
ShangPharma Innovation Names Two Executives-In-Residence | PR Newswire | 10/24/2017
… a global venture capital firm and innovation incubator focused on biomedical R&D therapeutics and technologies, announced the appointment of Dirk G. Brockstedt , Ph.D., and Benson Tsang , MBA, to its Executive-In-Residence (EIR) team … About ShangPharma Innovation Inc. ShangPharma Innovation Inc. is a novel healthcare venture capital firm founded in the U.S. in 2016. ShangPharma Innovation accelerates and facilitates pharmaceutical discovery and development – focusing on therapeutics and technology platforms …
About:
Editor:
